Related Experiment Video
Updated: Jun 24, 2025

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue
Published on: January 3, 2013
Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis
Susana Castro-Pando1, Rian M Howell2, Le Li2
1Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Interleukin-17 receptor A (IL17RA) in pancreatic epithelial cells drives pancreatic cancer by suppressing anti-tumor immunity. Targeting IL17RA or its downstream target B7-H4 may offer new strategies for early pancreatic cancer interception.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Interleukin-17 (IL17) signaling is implicated in pancreatic cancer initiation and progression.
- The specific cellular sources and molecular mechanisms of IL17-driven pancreatic tumorigenesis remain incompletely understood.
Purpose of the Study:
- To elucidate the cellular compartment and molecular mediators of IL17-driven pancreatic cancer.
- To investigate the role of IL17 receptor A (IL17RA) in pancreatic epithelial cells versus hematopoietic cells.
Main Methods:
- Generated IL17RA-deficient bone marrow chimeras with IL17RA deleted in either pancreatic epithelial or hematopoietic compartments.
- Utilized embryonically activated or inducible Kras models for pancreatic tumorigenesis.
- Analyzed transcriptional profiles and immune cell infiltration in tumor microenvironments.
- Assessed the impact of genetic deletion of the B7-H4 immune checkpoint molecule.
Main Results:
- Epithelial-specific deletion of IL17RA significantly delayed pancreatic premalignant lesion development and increased CD8+ T cell infiltration.
- Absence of IL17RA in pancreatic epithelial cells altered gene expression related to stemness and immune pathways.
- B7-H4 was identified as a key IL17-upregulated immune checkpoint molecule; its deletion also delayed tumor development and reduced immunosuppression.
Conclusions:
- Pancreatic epithelial IL17RA promotes tumorigenesis by reprogramming the tumor immune microenvironment, partly via B7-H4.
- These findings reveal critical mechanisms of IL17 in pancreatic cancer and suggest potential targets for early immune interception.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

